Inhibition by trifluoperazine of glycogenolytic effects of phenylephrine, vasopressin, and angiotensin II.

The effects of trifluoperazine on the activation of glycogenolysis by various hormones were studied in perfused rat liver. Trifluoperazine significantly inhibited glycogenolytic effect of phenylephrine and angiotensin II by lowering maximal response, and that of vasopressin by shifting the dose-response curve to the right, while alpha-antagonist phentolamine was inhibitory only to phenylephrine. Phosphorylase activation of phenylephrine was inhibited by trifluoperazine in parallel with glycogenolytic response. The increase in 45Ca2+ efflux induced by phenylephrine, angiotensin II, and vasopressin was also inhibited by the agent. These inhibitory effects of trifluoperazine were not related to the change in tissue cyclic AMP or cyclic GMP levels. On the other hand, neither the glycogenolytic effect of glucagon, cyclic AMP, and N6,O2-dibutyryl cyclic AMP nor phosphorylase activation by glucagon was affected by trifluoperazine. Thus, trifluoperazine specifically inhibits the activation of glycogenolysis by Ca2+-dependent hormones.

[1]  U. Schubart,et al.  Effect of trifluoperazine, D600, and phenytoin on depolarization- and thyrotropin-releasing hormone-induced thyrotropin release from rat pituitary tissue. , 1981, Endocrinology.

[2]  L. Tilley,et al.  Inhibition of phenylephrine‐stimulated gluconeogenesis by chlorpromazine is mediated by α‐adrenergic receptors , 1981, FEBS letters.

[3]  B. P. Hughes,et al.  Blockade of hepatic α‐adrenergic receptors and responses by chlorpromazine and trifluoperazine , 1981 .

[4]  P. Reinhart,et al.  Trifluoperazine, an inhibitor of calmodulin action, antagonises phenylephrine‐induced metabolic responses and mitochondrial calcium fluxes in liver , 1980, FEBS letters.

[5]  J. McDonald,et al.  Calmodulin-sensitive ATP-dependent Ca2+ transport across adipocyte plasma membranes. , 1980, The Journal of biological chemistry.

[6]  J. Williamson,et al.  Hormonal effects on calcium homeostasis in isolated hepatocytes. , 1980, The Journal of biological chemistry.

[7]  K. Walsh,et al.  Stimulation of phosphorylase b kinase by the calcium-dependent regulator. , 1980, The Journal of biological chemistry.

[8]  W. Y. Cheung,et al.  Calmodulin plays a pivotal role in cellular regulation. , 1980, Science.

[9]  N. Friedmann,et al.  Effects of the calcium ionophore A23187 on liver metabolism. , 1979, The Journal of pharmacology and experimental therapeutics.

[10]  J. Garrison,et al.  The role of calcium ion as a mediator of the effects of angiotensin II, catecholamines, and vasopressin on the phosphorylation and activity of enzymes in isolated hepatocytes. , 1979, The Journal of biological chemistry.

[11]  P. Blackmore,et al.  Studies on alpha-adrenergic activation of hepatic glucose output. The role of mitochondrial calcium release in alpha-adrenergic activation of phosphorylase in perfused rat liver. , 1979, The Journal of biological chemistry.

[12]  P. Cohen,et al.  Identification of the Ca2+‐dependent modulator protein as the fourth subunit of rabbit skeletal muscle phosphorylase kinase , 1978, FEBS letters.

[13]  P. Blackmore,et al.  Studies on alpha-adrenergic activation of hepatic glucose output. Relationship between alpha-adrenergic stimulation of calcium efflux and activation of phosphorylase in isolated rat liver parenchymal cells. , 1978, The Journal of biological chemistry.

[14]  J. H. Wang,et al.  The modulator-dependent protein kinase. A multifunctional protein kinase activatable by the Ca2+-dependent modulator protein of the cyclic nucleotide system. , 1978, The Journal of biological chemistry.

[15]  D. Babcock,et al.  Norepinephrine, vasopressin, glucagon, and A23187 induce efflux of calcium from an exchangeable pool in isolated rat hepatocytes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[16]  F. Vincenzi,et al.  Phosphodiesterase protein activator mimics red blood cell cytoplasmic activator of (Ca2+-Mg2+)ATPase. , 1977, Biochemical and biophysical research communications.

[17]  H. Jarrett,et al.  Partial purification of the Ca2+-Mg2+ ATPase activator from human erythrocytes: its similarity to the activator of 3':5' - cyclic nucleotide phosphodiesterase. , 1977, Biochemical and biophysical research communications.

[18]  P. Blackmore,et al.  Studies on alpha-adrenergic activation of hepatic glucose output. Studies on role of calcium in alpha-adrenergic activation of phosphorylase. , 1977, The Journal of biological chemistry.

[19]  B. Weiss,et al.  Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain. , 1976, Molecular pharmacology.

[20]  D. Steinberg,et al.  Stimulation of rat liver phosphorylase kinase by micromolar concentrations of Ca2+ , 1975, FEBS letters.

[21]  C. Kirk,et al.  Hepatic action of vasopressin: Lack of a role for adenosine‐3′,5′‐cyclic monophosphate , 1974, FEBS letters.

[22]  F. Nuttall,et al.  Radioactive method for the assay of glycogen phosphorylases. , 1972, Analytical biochemistry.

[23]  C W Parker,et al.  Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. , 1972, The Journal of biological chemistry.

[24]  D. Kipnis,et al.  Radioimmunoassay for cyclic nucleotides. II. Adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in mammalian tissues and body fluids. , 1972, The Journal of biological chemistry.

[25]  W. Glinsmann,et al.  Similarities between effects of adenosine 3',5'-monophosphate and guanosine 3' 5'-monophosphate on liver and adrenal metabolism. , 1969, Endocrinology.

[26]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.